Viewing Study NCT06639230



Ignite Creation Date: 2024-10-25 @ 7:57 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06639230
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-10

Brief Title: Effect of Laser and Sclerotic Agent in the Treatment of Oral Granuloma
Sponsor: None
Organization: None

Study Overview

Official Title: A Comparative Randomized Clinical Study on the Recurrence Rate of Gingival Pyogenic Granuloma Treated with Sclerotherapy Versus Diode Laser Therapy
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Pyogenic granuloma is a common tumor-like growth of the oral cavity considered to be non-neoplastic in nature They usually present as a reactive lesion occur in response to chronic and recurring tissue injury in which capillaries are very prominent commonly seen arising from interdental gingiva Pyogenic granuloma may occur in all ages with a peak age of incidence in the second decade of life more common in young adult females possibly because of vascular effects of female hormones
Detailed Description: Oral PG can be treated by conservative excision Local irritants or the source of trauma must be eliminated to minimize the risk of recurrence Although surgical excision is considered a simple procedure it might be complicated by several complications such as intraoperative bleeding and postoperative infection that might delay the healing of the wound Other treatment modalities such as laser injection of sclerosing agents have been used

Laser has proven to be an effective therapy for oral soft tissue pathologies Moreover its ability to perform precise incisions better hemostasias and less invasive procedures with less discomfort to patients have made it a preferred treatment option for several soft tissue lesions

Sclerotherapy has been proposed as an effective method of treatment for pyogenic granuloma Their mechanism of action is endothelial injury inflammation thrombosis fibrosis and final lesion destruction Polidocanol is a widely used nonionic detergent sclerosant that was first developed as an anesthetic It acts through endothelial overhydration vascular injury and closure

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None